acarbose
The aim of this study was to evaluate the safety and efficacy of       24 weeks of treatment with 300 mg acarbose per day in 76 consecutive outpatients        affected by type 2 diabetes and well-compensated liver cirrhosis.
The aim of this study was to evaluate the safety and efficacy of       24 weeks of treatment with 300 mg  @SUBJECT$  per day  @PREDICAT$  76 consecutive  @OBJECT$         affected by type 2 diabetes and well-compensated liver cirrhosis.